title: Common sense treatment for common lipid disorders.
abstract: Dyslipidemia is a common, major modifiable risk factor for cardiovascular disease. Screening for lipid disorders is simple, and available treatments decrease disease risk. However, secondary causes of dyslipidemia are probably underappreciated, and severe lipid elevations should be referred to a lipid specialist. Patients usually respond to lifestyle modifications and drug therapy guided by a stepwise approach supported by the results of clinical trials, but several misconceptions may interfere with treatment strategies.
authors.affiliation: Division of Endocrinology, Metabolism, and Lipid Research, Washington University, St. Louis, USA. mkjohnson@dom.wustl.edu
authors.forename: Mariko
authors.initials: M
authors.lastname: Johnson
authors.forename: Clay F
authors.initials: CF
authors.lastname: Semenkovich
mesh_terms: D008078:Cholesterol, LDL / Q000097:blood; D015897:Comorbidity; D003925:Diabetic Angiopathies / Q000097:blood / Q000188:drug therapy; D050171:Dyslipidemias / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000494:pharmacology; D015228:Hypertriglyceridemia / Q000188:drug therapy / Q000209:etiology; D008019:Life Style
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors